Clinical Trial
RESULTS
Research Sponsor: MedImmune, LLC
Drugs Studied: MEDI3250 (FluMist速 Quadrivalent)
National Clinical Trial #: NCT02473510
Protocol #: D2560C00009
Study Date: June 2015 to January 2016
Short Study Title: A study to determine the safety of a new
investigational form of FluMist速 in healthy adults
Thank you!
As a clinical study participant, you belong to a large community
of participants around the world. You help researchers answer
important health questions and discover new medical treatments.
Thank you for taking part in the clinical study for a new form of
FluMist速. This vaccine is being developed to prevent influenza, or the
flu. You and all of the participants helped researchers learn about the
safety of this form of FluMist速.
MedImmune, LLC, the sponsor of this study, thanks you for your
help and thinks it is important for you to know the results of your
study. An independent non-profit organization called CISCRP
prepared this summary of the study results for you with the help of
a medical writing organization. We hope it helps you understand and
feel proud of your important role in medical research. If you have
questions about the results, please speak with the doctor or staff
at your study site.